Preserved incretin activity of glucagon-like peptide 1736 amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
Bariatric Surgery: Understanding the Limitations While GLP-1 agonists have revolutionized the approach to weight loss, its critical to understand that their efficacy has limitations, particularly in individuals with morbid obesity (Body Mass Index [BMI] 40 kg/m)
From a translational perspective, combining GLP-1RAs with interventions that selectively increase vagal afferentNTS signaling represents a promising approach
People who made dosing errors while administering semaglutide from compounding pharmacies have been harmed and even hospitalized after accidentally taking too much, according to an alert issued last week by the FDA
C.SahaM.BlanchardS.SchirrmacherP.FinkP.VerheggenF.et al
Reduces Inflammation Chronic inflammation is a key driver of many health issues, including heart disease, diabetes, and autoimmune disorders